The German Lipoprotein Apheresis Registry—Summary of the ninth annual report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The German Lipoprotein Apheresis Registry—Summary of the ninth annual report

Published:2022-12 Issue:S1 Volume:26 Page:81-88
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Schettler Volker J. J.¹^ORCID,Peter Christian²,Zimmermann Thomas³,Julius Ulrich⁴,Roeseler Eberhard⁵,Schlieper Georg⁵,Heigl Franz⁶,Grützmacher Peter⁷,Löhlein Iris⁸,Klingel Reinhard⁹,Hohenstein Bernd¹⁰^ORCID,Ramlow Wolfgang¹¹,Vogt Anja¹²,

Affiliation:

1. Center of Nephrology Göttingen GbR Göttingen Germany

2. akquinet tech@spree GmbH, Rostock Division Rostock Germany

3. BioArtProducts GmbH (B.A.P.) Rostock Germany

4. Department of Medicine III University Hospital Carl Gustav Carus at the Technische Universität Dresden Dresden Germany

5. Center for Nephrology, Hypertension, and Metabolic Diseases Hannover Germany

6. Medical Care Center Kempten‐Allgäu Kempten Germany

7. AGAPLESION MVZ Markus Hospital Frankfurt Germany

8. German Society of Lipidology and resulting affections (DGFF) Frankfurt Germany

9. Apheresis Research Institute Cologne Germany

10. Nephrological Center Villingen‐Schwenningen Villingen‐Schwenningen Germany

11. Apheresis Center Rostock (ACR) Rostock Germany

12. Medizinische Klinik und Poliklinik 4 Universität München Munich Germany

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13780

Reference23 articles.

1. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities

2. Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias

3. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

4. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

5. Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for management of patients with elevated lipoprotein(a);Current Opinion in Lipidology;2024-08-14

2. Lipoprotein(a) - gaining clinical importance as a cardiovascular risk factor. Current state of medical knowledge.;Prospects in Pharmaceutical Sciences;2024-08-14

3. A multi‐institutional survey of apheresis services among institutions in the United States;Journal of Clinical Apheresis;2024-07-09

4. Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis;Therapeutic Apheresis and Dialysis;2024-06-04

5. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels;Archives of Medical Science;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3